Introducing Flyte®
The first and only pelvic floor device to deliver the proven treatment modality of mechanotherapy to the pelvic floor, Flyte is transforming the standard of care for urinary
incontinence.
What is Flyte?
Flyte enables you to extend your clinic walls into your patients’ homes with the fastest, most effective
in-home treatment for stress urinary incontinence and weak pelvic floor muscles.
- Recommended by healthcare professionals
- Originally developed at the Arctic University of Norway by researchers, physicians, and
experts in the field of pelvic floor health - Continence rates and durability of treatment effect comparable to surgery, as demonstrated
in two clinical trials - Fastest in-home treatment available
- FDA-cleared
Flyte is the new gold standard for conservative treatment of SUI and weak pelvic floor muscles.
1. Continence rates & durability comparable to surgery [1, 2]
- 83% achieve continence in only 6 weeks (71% when including the highest severity SUI)
- 77% still continent 2 years post treatment
2. Fast & Easy
- 5 minutes a day for 6 weeks at-home or in the clinic
- No ongoing maintenance typically required
3. Clinically Proven
- 2 substantiative clinical trials, 179 subjects [1, 2] , including one of the largest randomized
double-blind studies of SUI
- Proven effective for mild, moderate, and severe SUI [1]
4. Unique Mechanism of Action
- Only product to use mechanotherapy, a proven treatment modality foundational to physical
therapymuscle rehabilitation [3]
- Gentle mechanical (not electrical) pulses paired with active pelvic floor movement for
cellular level tissue repair and facilitation of neuromuscular memory
5. Expert Support
- We empower women and clinicians with a complimentary Ask A (Pelvic) Physical Therpist
service, private Facebook community monitored by pelvic PTs, and free educational content
A foundational treatment modality that actively treats and tones pelvic floor muscles, which has been proven to treat SUI
Flyte Delivers Mechanotherapy
Flyte is the first and only intravaginal pelvic floor device that uses mechanotherapy to effectively
improve SUI by strengthening and toning pelvic floor muscles.
Mechanotherapy is the clinical application of mechanotransduction for tissue repair and healing.
Mechanotransduction is the scientific process in which cells sense and respond to mechanical stimuli (such as the mechanical oscillations of the Flyte wand), triggering a cascade of events that lead to cellular-level changes in muscle tissue. In this process, mechanical stimuli disrupt the cell’s tensional integrity and tissues respond reflexively by increasing actin and myosin myofilament recruitment to restore structural tone.
On a neuromuscular level, the mechanical vibrational stimulation can induce non-voluntary muscular
contraction through tonic vibration reflex (TVR), activating the proprioceptive sensory system and
facilitating neuromuscular memory.
The result is improved clinical outcomes compared to traditional Pelvic Floor Muscle Training (Kegels), Kegel trainers and electrical stimulation devices.
The Positive Effects of Mechanotherapy
Expand Your Clinic Walls
Women today are looking for effective and convenient treatment options that support their physical and mental needs while fitting into their lifestyle. As awareness of the importance of pelvic health increases, demand for effective and specialized care is greater, intensifying access to care challenges - and highlighting the need for evidence-based resources to support patient care, accelerate positive outcomes, and reduce unnecessary costs. Flyte empowers you to provide this level of care to your patients.
How Can Your Patient Get Flyte?
Flyte is FDA-cleared for OTC and prescription use.
- We offer discount codes to healthcare providers and patients purchase directly on our
website with your discount code.
- We offer reseller agreements to providers and clinics for patients to purchase directly from
you. Available in packs of 4 Flyte units at a discounted price.
By collaborating with healthcare professionals, we are bridging the gap between in-clinic patient care
and the need for greater support for women with urinary incontinence.
Flyte is a safe and effective alternative to surgery to treat stress urinary incontinence and improve pelvic floor muscle tone.
See what doctors and patients are saying about Flyte
We love hearing our on-staff pelvic floor physical therapists spread awareness, education, and support.
Use this advanced section to build your own layouts or to add custom HTML, Liquid, or scripts.
References:
1. Nakib N, Sutherland S, Hallman K. Novel Pelvic Floor Treatment with Mechanotherapy: Final Clinical
Trial Results in Women with Stress Urinary Incontinence (SUI). Neurourology and Urodynamics.
Published online 2020. Accessed June 10, 2023. https://www.ics.org/2020/abstract/26.
2. Nilsen I, Rebolledo G, Acharya G, Leviseth G. Mechanical oscillations superimposed on the pelvic floor
muscles during Kegel exercises reduce urine leakage in women suffering from stress urinary
incontinence: A prospective cohort study with a 2-year follow up. Acta Obstet Gynecol Scand. 2018
Oct;97(10):1185-1191. Doi: 10.1111/aogs.13412. Epub 2018 Aug 2. PMID: 29923602.
3. Fulker, A., Kovela, S., Minalli, M. (2023). Science and Mechanism of Action for Clinical Rehabilitation of
Female Stress Urinary Incontinence. [Unpublished manuscript].
4. Data on file at Flyte by Pelvital.
5. Gao, Jiejun MD; Liu, Xinru PhD∗; Zuo, Yan MD; Li, Xiaocui MD. Risk factors of postpartum
stress urinary incontinence in primiparas: What should we care. Medicine 100(20):p e25796,
May 21, 2021. | DOI: 10.1097/MD.0000000000025796
6. Wesnes SL, Hunskaar S, Bo K, Rortveit G. The effect of urinary incontinence status during
pregnancy and delivery mode on incontinence postpartum. A cohort study. BJOG. 2009
Apr;116(5):700-7. doi: 10.1111/j.1471-0528.2008.02107.x. Epub 2009 Feb 10. PMID: 19220234;
PMCID: PMC2675011.
7. Fritel X, Fauconnier A, Levet C, Bénifla JL. Stress urinary incontinence 4 years after the first
delivery: a retrospective cohort survey. Acta Obstet Gynecol Scand. 2004 Oct;83(10):941-5. doi:
10.1111/j.0001-6349.2004.00457.x. PMID: 15453890; PMCID: PMC2662093.
8. MacArthur, C. et al. (2015). Urinary incontinence persisting after childbirth: Extent, delivery history,
and effects in a 12-year longitudinal cohort study. BJOG: An International Journal of Obstetrics &
Gynaecology, 123(6), 1022–1029. https://doi.org/10.1111/1471-0528.13395
9. Flyte by Pelvital Market Research.
10. Cheng S, Lin D, Hu T, Cao L, Liao H, Mou X, Zhang Q, Liu J, Wu T. Association of urinary incontinence
and depression or anxiety: a meta-analysis. J Int Med Res. 2020 Jun;48(6):300060520931348. doi:
10.1177/0300060520931348. PMID: 32552169; PMCID: PMC7303787.
11. Datar, M., Pan, L., McKinney, J. L., Goss, T. F., & Pulliam, S. J. (2022). Healthcare resource use and
cost burden of urinary incontinence to United States payers. Neurourology and Urodynamics, 41(7),
1553-1562. https://doi.org/10.1002/nau.24989